Emergent Ventures, fourth cohort of award recipients

Kadeem and Savannah Noray, graduate students at Harvard, economics and HKS, general support and also to study how to identify undervalued, high potential K-12 students.

José Luis Ricón, for blogging and to develop further platforms for information dissemination. 

Arun Johnson, high school student in the Bay Area, to advance his work in physics, chemistry, nuclear fusion, and for general career development.

Thomas McCarthy, undergraduate at Dublin, Trinity College, travel grant to the Bay Area, and for his work on nuclear fusion and running start-up programs to cultivate young Irish entrepreneurs.

Natalya Naumenko, economist, incoming faculty at George Mason University, to study the long-term impact of nuclear explosions on health, and also more broadly to study the history of health in the Soviet Union and afterwards.  

Paul Novosad, with Sam Asher, assistant professor at Dartmouth, to enable the construction of a scalable platform for the integration and dissemination of socioeconomic data in India, ideally to cover every town and village, toward the end of informing actionable improvements.

Alexey Guzey, travel grant to the Bay Area, for blogging and internet writing, plus for working on systems for improving scientific patronage.

Dylan DelliSanti, to teach an economics class to prisoners, and also to explore how that activity might be done on a larger scale.

Neil Deshmukh, high school student in Pennsylvania, for general career support and also his work with apps to help Indian farmers identify crop disease and to help the blind interpret images.

Here is my previous post on the third cohort of winners, with links to the first and second cohorts.  Here is my post on the underlying philosophy behind Emergent Ventures.  You can apply here.

Comments

Curious what the average amount of Grant is.

It's the sum of grants divided by the number of grants.

Give this one a grant (average-sized)

"José Luis Ricón, for blogging" - what? You can get paid to blog? Why isn't anybody paying me?

I notice a lot of nuclear ideas...that's actually the future, since fossil fuels will run out soon. Already fracked sites are running out of oil faster than expected. Like squeezing a nearly empty tube of toothpaste, you get a nice "pop" and then it suddenly is dry. For this reason there's record low natural gas prices, since natural gas follows oil once oil is depleted in a field. That's what's happening now. Peak Oil lives...

Do you have a blog?
Or do you mean posting on this?

"fossil fuels will run out soon": I've been hearing that for many decades. Though I'll grant not for as long as I've heard that controlled fusion is only forty years away.

You have to be good at blogging to get paid for it, generally.

@Anonymous2 - 'good' as in attract eyeballs? That's why the pop sites and fake news sites--save this site--get so many eyeballs. To see how 'good' they really are, do a "CNTRL + F + "PATENT"" and hit Enter, see how many hits you get (zero). And often that's on a blog that's discussing technology and how to increase innovation!

Bonus trivia: excellent book on PCR: "Making PCR" by Paul Rabinow. Shows you how team invention is done. Helps to have a cartoon understanding of recombinant DNA, PCR, nucleotides, and other basic, easy to understand processes (easy to understand ex post but hard ex ante, I mean, how can you get a primer to bind to a specific codon sequence? To get a restriction enzyme and ligase to work on a specific portion of DNA? That must take years of effort! But you don't hear about these 'team' player inventors, just the superstars like K. Mullis. This book attempts to address this imbalance a bit. And you'll learn how the FDA put Cetus out of business by delaying --after the rest of the world had approved--their superstar biotech drug IL-2, still used today, and other drugs (a Hep C antivirus drug), see more here: https://www.the-scientist.com/news/cetus-a-collision-course-with-failure-60308 (downplays the role the FDA played, but good overview). Note how Cetus, despite inventing PCR, did not make money off of it (neither the company, nor principal inventor K. Mullis, though he had a slew of co-inventors), a failure of existing patent laws. Note also animal trial success does not equal human trial success, something a lot of animal lovers don't realize. Should chimps be guinea pigs?

Nintil is one of the best blogs out there so I'm glad Jose Luis Ricon has become a recipient! Congratulations

Thanks! :)

I thank President Captain Bolsonaro.

Dylan DelliSanti's work sounds very interesting. Look forward to seeing the results.

Thank you for the tip.

The thanks was meant to be directed to Iskander.

Guzey is great, glad to see him on here.

Travel grant to the Bay Area? Second prize is two travel grants to the Bay Area.

Funding nuclear fusion seems a lot more about signaling than expecting anything from these particular ventures.

I interpret the signaling portion as a feature, not a bug. Seems that an important driver of value in this project is increasing the status/value of ambition in general.

Comments for this post are closed